Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 9 ... half of 2010. The Cephalon pipeline of pain products includes intravenous celecoxib and two tamper-deterrent opioid medications. Earlier this year, Cephalon completed the ...
2009 NOV 9 ... too long for chemoprevention of gastric cancer. According to the findings of this study, Celecoxib may have effects including anti-oncogenic effect, inhibition of angiogenesis and ...
2009 NOV 30 ... "The aim of this study was to investigate the antifibrotic effects of celecoxib, a selective COX-2 inhibitor. The effects of various COX inhibitors-that is, ibuprofen, ...
2009 NOV 1 ... and prostaglandin E2, it was reasoned that a combination therapy of erlotinib and celecoxib would be effective in controlling papilloma growth. After institutional approval and ...
2009 NOV 23 ... selectivity ratio (from weak COX-2 preferential inhibitors to compounds displaying a celecoxib-like selectivity profile) were further evaluated in vivo in a model of A ...
2009 NOV 16 ... recovery after major surgery - a randomized double blind controlled trial of celecoxib or diclofenac vs. placebo.' According to a study from Australia, "Ileus occurs after ...
2009 NOV 2 ... the United States conducted a study "To assess the hepatic safety and tolerability of celecoxib versus placebo and three commonly prescribed nonselective nonsteroidal anti-inflammatory ...
2009 NOV 9 ... "The role of p53 mutation in the anti-tumour responses of the selective COX-2 inhibitor celecoxib in human glioblastoma cells is unknown. In this study, we used human glioblastoma cells ...
2009 NOV 16 ... applied to the prediction of food effects on the absorption of a poorly soluble drug, celecoxib, from 200 mg capsules," investigators in Frankfurt, Germany report. "A ...
2009 NOV 23 ... "We investigated the effectiveness of celecoxib in reducing symptoms in patients with difficult chronic pelvic pain syndrome (CPPS), NIH ...
2009 NOV 30 ... study explores the effects of p53-modulating agent CP-31398 alone and combined with celecoxib on azoxymethane-induced aberrant crypt foci (ACF) and colon adenocarcinomas in F344 ...
2009 NOV 2 ... results, 'Prolonged low-dose administration of the cyclooxygenase-2 inhibitor celecoxib enhances the antitumor activity of irinotecan against neuroblastoma xenografts,' are ...
2009 NOV 30 ... prostate cancer. We conducted a randomized, double-blind trial to examine the effect of celecoxib on drug-specific biomarkers from prostate tissue obtained at prostatectomy." ...
2009 NOV 30 ... critical molecules and signal pathways modulated by a combination of lovastatin and celecoxib in the human HCT-116 colon cancer cell line. HCT-116 cells were exposed to 50 mc M...
2009 NOV 2 ... According to a study from Clayton, Australia, "Celecoxib (Celebrex(™)), an inhibitor of cyclooxygenase-2 (COX-2; prostaglandin-endoperoxide ...
2009 OCT 19 ... and activity, we did comparative analyses after treatment with various drugs (EGF, celecoxib, prostaglandin E-2, gefitinib, Ro-31-8425, PD98059, and SP600125) in HCT-116-Mock versus ...
2009 NOV 16 ... overexpression of 12-R-LOX and COX-2 in A431 cells. Baicalein (a 12-LOX inhibitor) and celecoxib (a COX-2 inhibitor) significantly reduced thymidine incorporation, whereas ...
